BG
Bellevue Group Portfolio holdings
AUM
$5.28B
1-Year Est. Return
50.12%
This Fund
S&P 500
1 Year Est. Return
+50.12%
AUM
$5.28B
AUM Growth
+$464M
(+9.6%)
Holding
185
Top Buys
| 1 | +$120M | |
| 2 | +$105M | |
| 3 | +$102M | |
| 4 |
Krystal Biotech
KRYS
|
+$86.1M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$75.6M |
Top Sells
| 1 | +$149M | |
| 2 | +$139M | |
| 3 | +$113M | |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$109M |
| 5 |
argenx
ARGX
|
+$72.3M |
Sector Composition
| 1 | Healthcare | 99.71% |
| 2 | Technology | 0.1% |
| 3 | Consumer Discretionary | 0.05% |
| 4 | Financials | 0.03% |
| 5 | Communication Services | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDLN
76
Medline Inc
MDLN
$35.3B
| $4.94M | 0.09% |
+117,720
|
|
||
77
Adaptive Biotechnologies
ADPT
$2.35B
| $4.84M | 0.09% |
298,090
+129,614
|
|
||
78
Icon
ICLR
$8.16B
| $4.48M | 0.08% |
24,560
+313
|
|
||
79
BioNTech
BNTX
$26B
| $4.17M | 0.08% |
43,755
+9,800
|
|
||
80
BioMarin Pharmaceuticals
BMRN
$11.5B
| $3.86M | 0.07% |
65,008
-36,025
|
|
||
81
Bristol-Myers Squibb
BMY
$126B
| $3.62M | 0.07% |
67,082
+19,469
|
|
||
82
BrightSpring Health Services
BTSG
$7.31B
| $3.45M | 0.07% |
92,095
-98,429
|
|
||
83
NeoGenomics
NEO
$1.21B
| $3.27M | 0.06% |
278,286
-91,912
|
|
||
84
Avantor
AVTR
$5.85B
| $3.17M | 0.06% |
276,266
+172,904
|
|
||
85
Phreesia
PHR
$725M
| $3.1M | 0.06% |
183,213
-129,844
|
|
||
86
Beam Therapeutics
BEAM
$2.8B
| $3.09M | 0.06% |
111,510
-2,777,778
|
|
||
|
KMTS
87
Kestra Medical Technologies
KMTS
$1.32B
| $3.07M | 0.06% |
115,755
-12,956
|
|
||
88
Illumina
ILMN
$19.9B
| $3.01M | 0.06% |
22,940
-857
|
|
||
|
OMDA
89
Omada Health Inc
OMDA
$722M
| $2.81M | 0.05% |
177,897
-73,894
|
|
||
90
AstraZeneca
AZN
$309B
| $2.8M | 0.05% |
30,431
-5,213
|
|
||
91
Insmed
INSM
$31B
| $2.42M | 0.05% |
13,915
-6,336
|
|
||
92
Viking Therapeutics
VKTX
$3.81B
| $2.42M | 0.05% |
68,665
-7,417
|
|
||
93
Roivant Sciences
ROIV
$19.8B
| $2.34M | 0.04% |
+108,039
|
|
||
|
BBNX
94
Beta Bionics
BBNX
$550M
| $2.2M | 0.04% |
72,285
+8,002
|
|
||
95
State Street SPDR S&P 500 ETF Trust
SPY
$685B
| $2.11M | 0.04% |
3,100
|
|
||
96
Encompass Health
EHC
$10.7B
| $2.03M | 0.04% |
19,089
-103,869
|
|
||
97
United Therapeutics
UTHR
$22B
| $1.9M | 0.04% |
3,895
+1,255
|
|
||
98
BridgeBio Pharma
BBIO
$12.3B
| $1.84M | 0.03% |
24,111
+3,755
|
|
||
99
Brookdale Senior Living
BKD
$3.52B
| $1.81M | 0.03% |
167,444
+62,779
|
|
||
100
SI-BONE Inc
SIBN
$680M
| $1.78M | 0.03% |
90,331
-208,526
|
|